• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas.

作者信息

Edgren M, Eriksson B, Wilander E, Westlin J E, Nilsson S, Oberg K

机构信息

Department of Oncology, Akademiska sjukhuset, University Hospital, Uppsala, Sweden.

出版信息

Anticancer Res. 1997 Mar-Apr;17(2B):1303-9.

PMID:9137490
Abstract

Adrenocortical carcinoma (ACC) is a rare neoplasm with a poor prognosis. Prognostic factors are needed to identify patients who should be treated aggressively and those for which a less aggressive approach is warranted. As a result of advances within the field of immunohistochemistry, investigations of Ki-67, PCNA, IGF, EGF-r and p53 were performed in 17 ACC. The aim of this study was to clarify the role of Ki-67, PCNA, EGF-r, IGF and p53 in correlation to tumour behaviour and outcome. This retrospective study includes 16 patients, 10 women and 6 men, with a median age of 46 years. Nine tumours were hormonally functioning and 7 were non-functioning. The results obtained revealed that all tumours expressed PCNA and Ki-67 with median values of 59% and 14%, respectively, while p53 was negative in 88%, IGF negative in 82% and EGF-r positive in 94% of the tumours. No correlation was found between p53, IGF, EGF-r and survival rate. There was no interdependence between PCNA and Ki-67, or between PCNA, Ki-67 and the survival rate.

摘要

相似文献

1
Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas.
Anticancer Res. 1997 Mar-Apr;17(2B):1303-9.
2
PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.PCNA-LII、Ki-67免疫染色、p53活性及组织病理学变量在预测甲状旁腺癌患者临床结局中的作用
Anticancer Res. 2006 Mar-Apr;26(2A):1305-8.
3
PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.人膀胱移行细胞癌中PCNA/细胞周期蛋白的表达:其与Ki-67及表皮生长因子受体免疫染色的相关性
Pathologica. 1994 Apr;86(2):161-6.
4
Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.结直肠癌中增殖标志物、p53表达与组织学结果的相关性
J Gastrointestin Liver Dis. 2007 Jun;16(2):133-9.
5
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.血吸虫病相关的、器官局限型、肌层浸润性膀胱癌:凋亡标志物、增殖标志物、p53、E-钙黏蛋白、表皮生长因子受体及c-erbB-2的预后价值
J Urol. 2001 May;165(5):1481-7.
6
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.转化生长因子α、表皮生长因子受体、p53和Ki67在结直肠癌肝转移及相应原发性肿瘤中的临床相关性
Hepatology. 1998 Oct;28(4):971-9. doi: 10.1002/hep.510280411.
7
Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.非小细胞肺癌中p53免疫反应性、核仁组织区及增殖细胞核抗原的评估
Anticancer Res. 2000 Jan-Feb;20(1B):505-10.
8
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.无功能(静止性)垂体腺瘤的临床肿瘤生长及其与增殖标志物的比较
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):80-5. doi: 10.1055/s-2007-991131. Epub 2007 Dec 10.
9
DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.DNA拓扑异构酶IIα和Ki-67在人类肾上腺皮质肿瘤中的表达:腺瘤与癌之间可能的分化标志物
Mod Pathol. 1997 Sep;10(9):901-7.
10
The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.p53/p21WAF1 通路的异常在胃肠道间质瘤的发病机制和进展中起重要作用。
Oncol Rep. 2008 Jan;19(1):49-56.

引用本文的文献

1
The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms.免疫组织化学标志物在肾上腺皮质肿瘤诊断和预后中的作用
J Pers Med. 2021 Mar 15;11(3):208. doi: 10.3390/jpm11030208.
2
Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.肾上腺皮质肿瘤的免疫组化生物标志物。
Endocr Pathol. 2018 Jun;29(2):137-149. doi: 10.1007/s12022-018-9525-8.
3
Novel targeted therapies in adrenocortical carcinoma.肾上腺皮质癌的新型靶向治疗
Curr Opin Endocrinol Diabetes Obes. 2016 Jun;23(3):233-41. doi: 10.1097/MED.0000000000000247.
4
Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.肾上腺皮质癌细胞中β-连环蛋白的缺失会导致生长抑制和上皮-间质转化的逆转。
Oncotarget. 2015 May 10;6(13):11421-33. doi: 10.18632/oncotarget.3222.
5
IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.胰岛素样生长因子2(IGF2)促进肾上腺皮质癌细胞的生长,但其过表达不会改变肾上腺皮质癌的表型和分子特征。
PLoS One. 2014 Aug 4;9(8):e103744. doi: 10.1371/journal.pone.0103744. eCollection 2014.
6
Adrenocortical carcinoma: the management of metastatic disease.肾上腺皮质癌:转移性疾病的管理
Crit Rev Oncol Hematol. 2014 Nov;92(2):123-32. doi: 10.1016/j.critrevonc.2014.05.009. Epub 2014 Jun 4.
7
Genetics and epigenetics of adrenocortical tumors.肾上腺皮质肿瘤的遗传学和表观遗传学。
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9.
8
Current and emerging therapies for advanced adrenocortical carcinoma.晚期肾上腺皮质癌的现有和新兴疗法。
Oncologist. 2011;16(1):36-48. doi: 10.1634/theoncologist.2010-0270. Epub 2011 Jan 6.
9
Review paper: origin and molecular pathology of adrenocortical neoplasms.综述论文:肾上腺皮质肿瘤的起源与分子病理学
Vet Pathol. 2009 Mar;46(2):194-210. doi: 10.1354/vp.46-2-194.
10
Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.锌指转录因子Snail在肾上腺皮质癌中的表达与生存率降低相关。
Br J Cancer. 2008 Dec 2;99(11):1900-7. doi: 10.1038/sj.bjc.6604755. Epub 2008 Nov 18.